Skin Changes From the Use of Moisturizers in Participants With Cancer Experiencing Dermatological Adverse Events

Arms (1)

1. type

   EXPERIMENTAL

   label

   Moisturizer

   description

   Participants in this arm will apply the following cosmeceutical topical moisturizers twice daily (once in the morning and once in the evening) for the duration of the study: 1. La Roche Posay Lipikar wash Atopy-Prone Plus (AP+) moisturizing face and body wash (once in the morning and once in the evening) 2. La Roche Posay Lipikar AP+ triple repair moisturizing cream (once in the morning and once in the evening) 3. La Roche Posay Cicaplast balm Panthenol/Vitamin B5 (B5+) (once in the morning and once in the evening)

   interventionNames

   1. Other: La Roche Posay Lipikar Wash Atopy-Prone Plus (AP+) Moisturizing Face and Body Wash
   2. Other: La Roche Posay Lipikar AP+ Triple Repair Moisturizing Cream
   3. Other: La Roche Posay Cicaplast balm Panthenol/Vitamin B5 (B5+)

Primary outcomes (1)

1. measure

   Change in Patient-Reported Skin Dryness Severity

   timeFrame

   From baseline visit to follow-up visit (approximately 2-4 weeks).

   description

   Change in patient-reported skin dryness severity from baseline to follow-up visit (2-4 weeks) as measured by validated dryness severity scale (0-10 numerical rating scale where 0 = no dryness and 10 = severe dryness).